Aug
26
WallStreet Scope – Wednesday August 26th:
Matador Resources Company (MTDR) closed sub average on Tuesday with a 7 day performance of -15.72% ending the day at $19.14, down -1.64%. Shares traded at a volume of 1,086,063 shares and relative volume of 0.98. Matador Resources Company (MTDR) reported a quarterly performance of -29.40% and is trading from its 52 week low by 35.94% with a total debt to equity ratio of 0.42. Matador Resources Company (MTDR)’s performance per month stands at -6.63%, with a profit margin of -31.50%, total insider transactions 0.78% and has 85.37 million shares outstanding. Matador Resources Company (MTDR) is a buyer with an compiled analyst rating of 1.8 and EPS growth this year of 102.60%
MYR Group, Inc. (MYRG) of the General Contractors sector closed out the day Tuesday at $26.84, a loss of -1.32% with a return on investment of 11.50% trading at a volume of 133,411 shares. MYR Group, Inc. (MYRG) is performing below average with a weekly performance of -8.05% moving into this week with a quarterly performance of -9.63% and a 52 week low of 17.67%. MYR Group, Inc. (MYRG)’s monthly performance sits at -7.58%, profit margin 3.70%, -13.53% insider transactions. MYR Group, Inc. (MYRG) is a good stock in the General Contractors industry with an averaged analyst rating of 2.1 and EPS growth this year of 5.00%
Biota Pharmaceuticals, Inc. (BOTA) ended the day Tuesday at $2.01, a loss of -4.29%, after trading at a volume of 71,305 shares and market cap of 70.63. Biota Pharmaceuticals, Inc. (BOTA) is performing below average at a weekly performance of -12.61% and a quarterly performance of -6.51% off their 52 week low by 3.61%. Biota Pharmaceuticals, Inc. (BOTA)’s monthly performance is -12.99%, profit margin -32.50%, 246.55% insider transactions and for the upcoming day, Biota Pharmaceuticals, Inc. (BOTA) is neutral in the Biotechnology industry with an averaged analyst rating of 3 and EPS growth this year of -9.40%
La Jolla Pharmaceutical Co. (LJPC) of the Healthcare sector closed yesterday at $28.89 with a loss of -0.65%, trading at a volume of 152,482 shares. La Jolla Pharmaceutical Co. (LJPC) is performing above average with a weekly performance of 9.22% moving this week with a quarterly performance of 43.73% performing off their 52 week low by 301.25%. La Jolla Pharmaceutical Co. (LJPC)’s monthly performance is -1.83% , 82.20% insider transactions and, La Jolla Pharmaceutical Co. (LJPC) is a good stock in the Biotechnology industry with an averaged analyst rating of 1.6 and EPS growth this year of 83.60%
Grupo Financiero Galicia S.A. (GGAL) closed at $17.4 Tuesday, a gain of 0.23%, trading at a volume of 337,918 shares. Grupo Financiero Galicia S.A. (GGAL) is performing below average at a weekly performance of -16.14% moving into today with a quarterly performance of -16.75% and against their 52 week low by 69.12%. Grupo Financiero Galicia S.A. (GGAL)’s monthly performance of -3.87% , profit margin 32.90%. Grupo Financiero Galicia S.A. (GGAL) is a good stock in the Foreign Regional Banks industry with an averaged analyst rating of 2.4 and EPS growth this year of 77.10%
Open all references in tabs: [1 – 7]
Comments
Leave a Reply
You must be logged in to post a comment.